Challenges of extended venous thromboembolism prophylaxis in medical and surgical patients
- PMID: 35836745
- PMCID: PMC9250351
- DOI: 10.1590/1677-5449.202101951
Challenges of extended venous thromboembolism prophylaxis in medical and surgical patients
Abstract
Patients hospitalized for acute medical and surgical illnesses are at risk of developing venous thromboembolism (VTE) during hospitalization and after discharge. Extended pharmacological prophylaxis beyond the hospital stay is recommended for patients undergoing surgeries at high risk for VTE and for selected groups of hospitalized medical patients. This practice involves several challenges, from identification of at-risk populations eligible for extended prophylaxis to choice of the most appropriate anticoagulant and definition of the ideal duration of use. This review will present the main VTE risk assessment models for hospitalized medical and surgical patients, the current recommendations for use of extended prophylaxis, and its limitations and benefits.
Resumo: Pacientes hospitalizados por doenças clínicas e cirúrgicas agudas estão sob risco de desenvolvimento de tromboembolismo venoso (TEV) durante a hospitalização e após a alta. A profilaxia farmacológica estendida além do período da hospitalização é recomendada para pacientes submetidos a cirurgias de alto risco de TEV e para grupos selecionados de pacientes clínicos hospitalizados. Diversos desafios envolvem essa prática, desde o reconhecimento das populações de risco elegíveis para a extensão da profilaxia até a escolha do anticoagulante mais adequado e a definição do tempo ideal de utilização. Os principais modelos de avaliação de risco de TEV em pacientes clínicos e cirúrgicos hospitalizados, as recomendações atuais para uso da profilaxia estendida e suas limitações e benefícios serão apresentados nesta revisão.
Keywords: clinical protocols; disease prevention; patient safety; pulmonary embolism; risk management; venous thrombosis.
Copyright© 2022 The authors.
Conflict of interest statement
Conflicts of interest: MCC, ATCR, EFP and MAM receive honoraria from the pharmaceutical industry for lectures on anticoagulation.
Figures
Similar articles
-
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.Am J Med. 2020 May;133 Suppl 1:1-27. doi: 10.1016/j.amjmed.2019.12.001. Am J Med. 2020. PMID: 32362349
-
Decision support systems in clinical practice: The case of venous thromboembolism prevention.Int J Risk Saf Med. 2015;27 Suppl 1:S104-5. doi: 10.3233/JRS-150709. Int J Risk Saf Med. 2015. PMID: 26639683
-
Death Associated with Inadequate Reassessment of Venous Thromboembolism Prophylaxis at and after Hospital Discharge.Alta RN. 2015 Fall;71(3):26-8. Alta RN. 2015. PMID: 26638268
-
Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.Hosp Pract (1995). 2011 Aug;39(3):7-15. doi: 10.3810/hp.2011.08.574. Hosp Pract (1995). 2011. PMID: 21881387 Review.
-
A review of venous thromboembolism prophylaxis for hospitalized medical patients.Hosp Pract (1995). 2013 Aug;41(3):60-9. doi: 10.3810/hp.2013.08.1069. Hosp Pract (1995). 2013. PMID: 23948622 Review.
Cited by
-
Thromboprophylaxis in lower limb amputation surgery.J Vasc Bras. 2024 Aug 9;23:e20230144. doi: 10.1590/1677-5449.202301442. eCollection 2024. J Vasc Bras. 2024. PMID: 39286305 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources